Share
03.26_THECOVER

No Patient Left Behind: Expanding Semaglutide’s Reach

Recent studies from Endocrine Society journals have shown that GLP-1 RAs are not only successful in reducing obesity, but they have positive impacts on a range of other conditions. From improving taste sensitivity and positive results in a pediatric patient with several comorbidities to being an effective treatment in patients with a variety of psychiatric...
Share

Endocrine Society elects Wu as 2027-2028 President 

Joy-Wu-photo Endocrine Society members elected Joy Wu, MD, PhD, of the Stanford University School of Medicine in Stanford, Calif., as its 2027 – 2028 President. She will serve as president-elect for a year beginning in June 2026 before becoming president in June 2027.  Wu is the Gerald M. Reaven, MD Professor of Endocrinology, chief of the Division of Endocrinology and vice chair of basic...
Share

ENDO 2026 Offers the World of Endocrinology in the City of Chicago

Lange ENDO 2 Chicago is that “toddling town,” according to the immortal croonings of Frank Sinatra. It’s also set to become “endocrine central” when ENDO 2026 arrives June 13 – 16. Spread out along the shoreline of Lake Michigan, the Windy City is a quintessential American metropolis, with iconic skyscrapers, beautiful parks, charming neighborhoods, fabulous restaurants, and one...
Share

Endocrine Society Advocacy In Action – March 2026 

Endocrine Society Advocacy Win: Congress Increases FY 2026 NIH Funding  Last month, Congress finally passed a funding bill for the Department of Health & Human Services for fiscal year (FY) 2026. The bill includes an increase of about $415 million for the National Institutes of Health (NIH), including a $10 million increase for diabetes research, and language the Endocrine Society had advocated for to protect the NIH by limiting a budget...